Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
about
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis RestrictionThe anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer modelMulti-targeted therapy of cancer by niclosamide: A new application for an old drug.Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancerNifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model.Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma.Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer.Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles.IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages.Niclosamide: Beyond an antihelminthic drug.Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells.Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model.A Bystander Effect of Lung Cancer Chemotherapy on Chronic Echinococcal Disease.Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc.Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression.Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells
P2860
Q26743403-D286383A-CADE-432B-B679-F67FB277C31AQ28538542-0F0F81D9-8339-4554-939F-E2CDB4049AE7Q34199032-D144827F-25F5-4076-9B0D-BF6A54175CCBQ35150756-539EF8E7-CF6D-4CC1-A500-744E21C0B26AQ35274726-7719DC9A-B6FE-4160-A4CB-6B828793D5B3Q36266954-1672D039-9087-4F55-B9D3-1B5F75F3CBC4Q36962480-A430262E-E9CD-44E3-B558-305E36EF7415Q37725643-9BD84EC7-413F-4C67-8243-57C8E3049E00Q38887338-9E144F7A-6BD0-402C-AE8B-1C4E96C34D10Q38898133-CB5B1157-4DC8-4F3D-B84E-F628998D9190Q39153043-FE8B558E-6C5E-4687-A7A1-837D9DD03F05Q39227540-C0A5B204-7C6F-4968-ADD2-BB4425EDC9B2Q39727068-18DBB9B0-E13B-4813-98ED-134D261F4ACAQ40064435-DAC42E88-AA79-4B76-B1CE-5B30304CCBC9Q40104743-8FF98A67-1403-4CAD-8C35-132CB8E75916Q41634189-D1D1E803-3CDF-4710-B94E-8CCB0DDF2DEDQ41990323-5F0AADD7-4035-492D-83C9-E753EBD7C897Q46491430-BBD4A771-6548-4D9A-941E-7EC060FB770BQ47275485-77604977-92B0-44C7-BD2D-C5DB4844966DQ52807468-306747BD-845C-4AA5-9153-D09956EBD874Q55244874-3ED5DF70-8041-45CD-8C0C-047DB45485FAQ58691275-BE072D0D-8CC5-4404-96D8-1829CEA910CF
P2860
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@ast
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@en
type
label
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@ast
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@en
prefLabel
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@ast
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@en
P2093
P2860
P1433
P1476
Inhibition of STAT3 by niclosa ...... against head and neck cancer.
@en
P2093
Dong M Shin
Fadlo R Khuri
Gabriel L Sica
Walter J Curran
Xingming Deng
Zhongliang Hu
Zhuo G Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0074670
P407
P577
2013-09-03T00:00:00Z